These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35340932)

  • 1. Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation.
    Pradipta AR; Ahmadi P; Terashima K; Muguruma K; Fujii M; Ichino T; Maeda S; Tanaka K
    Chem Sci; 2021 Apr; 12(15):5438-5449. PubMed ID: 35340932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofunctional chemistry and reactivity of biogenic acrolein for cancer diagnosis and therapy.
    Pradipta AR; Tanaka K
    Chem Commun (Camb); 2021 Sep; 57(77):9798-9806. PubMed ID: 34581321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer approach by targeted activation of a global inhibitor of sialyltransferases with acrolein.
    Kasahara T; Chang TC; Yoshioka H; Urano S; Egawa Y; Inoue M; Tahara T; Morimoto K; Pradipta AR; Tanaka K
    Chem Sci; 2024 Jun; 15(25):9566-9573. PubMed ID: 38939146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of
    Ode Y; Pradipta AR; Ahmadi P; Ishiwata A; Nakamura A; Egawa Y; Kusakari Y; Muguruma K; Wang Y; Yin X; Sato N; Haba H; Tanaka K
    Chem Sci; 2023 Aug; 14(30):8054-8060. PubMed ID: 37538829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetramethylrhodamine is an essential scaffold of azide probe in detecting cellular acrolein.
    Pradipta AR; Fujii M; Tanei T; Morimoto K; Shimazu K; Noguchi S; Tanaka K
    Bioorg Med Chem; 2019 Jun; 27(11):2228-2234. PubMed ID: 31023557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general prodrug nanohydrogel platform for reduction-triggered drug activation and treatment of taxane-resistant malignancies.
    Yao J; Li T; Shi X; Wang Y; Fang S; Wang H
    Acta Biomater; 2021 Aug; 130():409-422. PubMed ID: 34087447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioorthogonal prodrug activation driven by a strain-promoted 1,3-dipolar cycloaddition.
    Matikonda SS; Orsi DL; Staudacher V; Jenkins IA; Fiedler F; Chen J; Gamble AB
    Chem Sci; 2015 Feb; 6(2):1212-1218. PubMed ID: 29560207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
    Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
    Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity.
    Smith RL; Åstrand OA; Nguyen LM; Elvestrand T; Hagelin G; Solberg R; Johansen HT; Rongved P
    Bioorg Med Chem; 2014 Jul; 22(13):3309-15. PubMed ID: 24842619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unexplored Chemical Reactions of Endogenous Acrolein: Detection, Toxicity, and Biological Roles].
    Pradipta AR; Tanaka K
    Yakugaku Zasshi; 2017; 137(3):301-306. PubMed ID: 28250324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-Responsive Prodrug Chemistries for Cancer Therapy.
    Bargakshatriya R; Pramanik SK
    Chembiochem; 2023 Sep; 24(18):e202300155. PubMed ID: 37341379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Prodrug-Payloads for Targeted Therapeutic Applications of Platinum-Acridine Anticancer Agents.
    Mancera-Ortiz IY; Chen J; Slade TA; Yao X; Zhang S; Day CS; Bierbach U
    Bioconjug Chem; 2023 Oct; 34(10):1873-1881. PubMed ID: 37813818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy.
    Cho H; Shim MK; Moon Y; Song S; Kim J; Choi J; Kim J; Lee Y; Park JY; Kim Y; Ahn CH; Kim MR; Yoon HY; Kim K
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water-dispersible fullerene aggregates as a targeted anticancer prodrug with both chemo- and photodynamic therapeutic actions.
    Fan J; Fang G; Zeng F; Wang X; Wu S
    Small; 2013 Feb; 9(4):613-21. PubMed ID: 23117954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
    Rono CK; Darkwa J; Meyer D; Makhubela BCE
    Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of cytochrome p450 genes for use in prodrug activation-based cancer gene therapy.
    Hecht JE; Waxman DJ
    Methods Mol Med; 2000; 35():77-83. PubMed ID: 21390800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
    Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
    Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From mechanism to mouse: a tale of two bioorthogonal reactions.
    Sletten EM; Bertozzi CR
    Acc Chem Res; 2011 Sep; 44(9):666-76. PubMed ID: 21838330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.